Hodgkins Lymphoma Cancer Studies Currently Recruiting Participants at the University of Chicago Comprehensive Cancer Center

	Study Number	Title
	12377A	Lymphoma Program Clinical Research Screening Protocol
Select	09-016-B	An Open-Label, Randomized, Parallel-Group Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in the First-Line Treatment of Patients with Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)
Select	09-180-A	Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed By ASCT In Relapsed or Refractory DLBCL
	10-064-B	Molecular characterization of hematopoietic malignancies
Select	10-406-A	CALGB 50801: Phase II Trial of Response-Adapted Therapy based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
	10-361-B	Prospective, Longitudinal, Multinational Registry of Patients with Newly Diagnosed Peripheral T-Cell Lymphoma
	10-558-B	Long Term Database Collection for Lymphoma
Select	11-0027	A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy (V212-011)
	11-0142	CALGB 50901: A Phase II Trial of Ofatumumab in Previously Untreated Follicular Non-Hodgkin's Lymphoma
	11-0601	Outcomes of Patients with Newly Diagnosed Peripheral T-cell Lymphoma Treated with Aggressive Chemotherapy
	11-0719	AN OPEN-LABEL, PHASE I, DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF GDC-0980 ADMINISTERED ONCE DAILY IN PATIENTS WITH REFRACTORY SOLID TUMORS OR NON-HODGKIN�S LYMPHOMA
	11-0726	Significance of Positron Emission Tomography Scan in Primary Mediastinal Large B-cell Lymphoma (PMBCL) and Mediastinal GreyZone (MGZL) Lymphoma
Select	11-0743	A Phase I, Open- Label, Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of V212/Inactivated Varicella- Zoster Virus (VZV) Vaccine in Adults with Hematologic Malignancies Receiving Treatment with Anti- CD20 Monoclonal Antibodies (V212- 013)
	12-1087	Comparison of Methylation Patterns By Age In Patients With Diffuse Large B-cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
	12-2190	An Open-label, Multicenter, Single-arm, Phase 2 Study of PCI-32765 (Ibrutinib) in Subjects with Refractory Follicular Lymphoma

To learn more about cancer clinical trials or to make an appointment, call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials). Although our objective is to provide an updated listing of clinical trials, please note that a listing here does not guarantee that a trial is open or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating physician.